News and Events

  • All
  • Awards
  • Community
  • Network Profile
  • Press Release
  • Research Highlight

GlycoNet Network Investigators play prominent role at 101st Canadian Chemistry Conference

Several GlycoNet Network Investigators were front and centre in an organizing role during the 101st Canadian Chemistry Conference and Exhibition (CSC) in Edmonton. Dr. Chris …

Indigenization of chemistry education top of mind for science educators

Exploring reconciliation in chemistry education session co-led by GlycoNet Network Investigator by Bernie Poitras Indigenous leaders, researchers, educators and science leaders across Canada discussed the …

Science, scenery, socks and social networking

Third annual Canadian Glycomics Symposium & AGM wraps up in majestic Canadian Rockies by Bernie Poitras More than 225 participants took part in the 2018 …

Precision Therapeutics Subsidiary, TumorGenesis, Announces License Agreement with 48Hour Discovery

MINNEAPOLIS, March 15, 2018 (GLOBE NEWSWIRE) — Precision Therapeutics Inc. (NASDAQ:AIPT) (“Precision” or “the Company”), formerly Skyline Medical, announced today that its wholly owned subsidiary, TumorGenesis Inc., …

Made to measure sugar-like molecule could improve cancer-fighting antibodies

GlycoNet funds project to produce fucosylation inhibitor for cancer therapies      by Bernie Poitras Dr. Robert Britton firmly believes every molecule is important. This chemist …

GlycoNet Chair Frank Gleeson announces launch of Satellos Bioscience Inc.

  We are delighted to congratulate our Chair, Frank Gleeson on the founding and launch of a new entrant on Canada’s biotechnology scene – Satellos …

Extraordinary $15 million gift will create unique powerhouse initiative to fight infections

Partnership will bring together over 250 researchers under the newly created McGill Interdisciplinary Initiative in Infection and Immunity

Carbohydrate biomarker improves screening for breast cancer patients

Precise blood test could prevent unnecessary cancer treatment

Research with made-in-Canada molecule targets fungal infections worldwide

GlycoNet project uses drug-like molecules that block attachment of cell surface glycoproteins to tackle big health problem

en_USEnglish
fr_CAFrench en_USEnglish
Scroll to Top